At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes.

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.

MiniMed (Nasdaq:MMED) announced today that it received FDA clearance for the MiniMed Flex next-generation insulin pump.

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).

MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO).

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.

Afon Technology says that its Glucowear non-invasive continuous glucose monitor (CGM) demonstrated significant accuracy in its first trial.

Insulet (Nasdaq:PODD) today initiated a voluntary medical device correction for specific lots of Omnipod 5 insulin pump pods.

The Accu-Chek SmartGUide with predictive AI. [Image courtesy of Roche] Glooko announced today that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM. The ...